Pyxis Oncology Statistics
NASDAQ: PYXSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.81+0.13 (+7.74%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Pyxis Oncology by the numbers
Pyxis Oncology has a market capitalization of $216.5 million based on 119.61M shares outstanding. With trailing EPS of $-1.27, Pyxis Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.9% below its 50-day average and 16.1% below its 200-day average.
Average daily trading volume is 1.06M shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PYXS valuation vs. peer median
| Metric | PYXS | Peer median | Difference |
|---|---|---|---|
| Market cap | $216.49M | $216.08M | +0% |
| Avg. volume | 1.06M | 799.55K | +33% |
Peer median across 8 companies: KROS, RCKT, ARCT, IMRX, ENTA, CYPH, VNDA, FTH.
Valuation
- Market cap
- $216.49M
- Price / sales (latest FY)
- 15.62
- EPS (TTM)
- $-1.27
- Shares outstanding
- 119.61M
Price and trading
- Previous close
- 1.68
- Open
- 1.70
- Day range
- 1.70 – 1.99
- 52-week range
- 1.03 – 5.55
- 52-week change
- -62.29%
- Beta
- —
- Volume
- 3.05M
- Average volume
- 1.06M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 216.49M
- Forward Pe
- -2.22
- Eps
- -1.27
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.55
- Week52 Low
- 1.03
- Avg Volume
- 1.06M
- Shares Outstanding
- 119.61M
- Ma50
- 2.13
- Ma200
- 2.16
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -67.39%
- Pct From52w Low
- 75.73%